BFRG: Bullfrog AI Holdings, Inc. Long-Term Loans to Capital Ratio

The Bullfrog AI bioinformatics team aims to transform pharmacology through AI developments. The history of long-term debt-to-equity demonstrates financial stability, where the 0.00 mark records this metric. High potential is driven by the bfLEAP drug discovery platform, while a strong market barrier is created by the complexity for partners to switch analytical software, ensuring margin stability.

The development of the bfLEAP platform for pharmaceuticals requires significant capital expenditures in AI infrastructure for Bullfrog AI Holdings (BFRG). Financing these costs through borrowed funds directly impacts the calculation of the long-term debt-to-equity ratio. This metric measures the proportion of loans with maturities exceeding one year relative to the company's equity. It reveals financial stability and the extent of the business's reliance on external leverage. Analyzing the long-term debt-to-equity ratio allows for an assessment of the balance between debt load and shareholder value.